On October 26th Dan spoke on a panel for SRZ’s annual event, discussing Sloane’s work for investor venBio in its proxy contest against Immunomedics, who Sloane now represents for ongoing PR/IR.
212.486.9500
Info@SloanePR.com
On October 26th Dan spoke on a panel for SRZ’s annual event, discussing Sloane’s work for investor venBio in its proxy contest against Immunomedics, who Sloane now represents for ongoing PR/IR.